Al Janaby, T., Khelwatty, S., Bagwan, I., Abbassi-Ghadi, N., & Modjtahedi, H. (2025). Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma. World Journal of Oncology. https://doi.org/10.14740/wjon2552